Skip to main content

Cardiology Update London 2019

The Royal Society of Medicine, London, UK
Type of event
on site


Dear Colleagues

It is a real pleasure to announce the 3rd Christmas Postgraduate Course of the Royal Brompton and Harefield NHS Foundation Trust & Imperial College, the Cardiology Update London.

Cardiology and cardiovascular medicine in general, is a rapidly expanding field with impressive developments and innovations over the last years. For physicians, be it general practitioners, cardiologists or cardiac surgeons, it is therefore important to keep pace with a challenging environment. To that end, we have designed a postgraduate course, the Cardiology Update London, to summarize, at the end of the year, the most important new developments, innovations, but also failures that will all affect cardiovascular diagnosis and management in our everyday practice.

We have selected an international Faculty of high standing experts both from the Trust and worldwide, covering the entire spectrum of cardiovascular medicine from prevention to intervention, from valvular heart disease to heart failure, and from conservative management to intervention and surgical operations. Thus, the course will give an up-to-date overview about current diagnosis and management of the most important cardiovascular conditions during two days in London.

We would be most happy to welcome you at the Royal Society of Medicine in central London to enjoy two days of interactive education for the benefit of your practice and your patients.

Yours sincerely,

Prof. Thomas F. Lüscher

Dr. Richard Grocott-Mason

Prof. Kim Fox

Dr. Bernard J. Gersh

Prof. Peter Libby

Dr. Ruth Amstein

In collaboration with



Mayo Clinic Logo


Under the Auspices of




Program Monday
Program Tuesday


Monday, December 16th, 2019

Venue: Royal Society of Medicine, London

08:30 - 08:45 | Welcome Address
08:30 The Royal Brompton & Harefield Hospital Trust T.F. Lüscher, London/Zurich, K. Fox, London and R. Grocott-Mason, London
08:40 Learning objectives and assessment R. Amstein, Zurich


08:45 - 09:45 | Opening Lectures: Frontiers in Cardiovascular Science
Chairs: K. Fox, London and R. Grocott-Mason, London
08:45 Opening Lecture1:
Artificial intelligence: What does it provide for medicine?
P.A. Friedman, Rochester
09:15 Opening Lecture 2:
Environmental hazards and cardiovascular diesease: A call for action
T. Münzel, Mainz
09:45-10:15 COFFEE BREAK  


10:15 - 13:00 | Session 1: Risk Factors and Prevention
Chairs: M.D. Lobo, London; R. Grocott-Mason, London and R.F. Storey, Sheffield
10:15 Hypertension: Drugs or devices? F. Mahfoud, Homburg/Saar
10:35 Dyslipidaemias: How do the new ESC Guidelines affect my practice? A.L. Catapano, Milan
10:55 Genetic tools to treat lipid disorders: PCSK9 inhibition and beyond K. Ray, London
11:15 Lipoprotein (a), a new risk factor? F. Mach, Geneva
11:35 Diabetes: New ESC Guidelines, new treatments F. Cosentino, Stockholm
11:55 Cardiovascular risk management in diabetes J. Deanfield, London
12:15 The microbiome as a new CV risk factor T.F. Lüscher, London/Zurich
12:35 Panel discussion all
13:00-14:00 LUNCH BUFFET  


14:00 - 16:15 | Session 2: Acute and Chronic Coronary Syndromes
Chairs: A. Baumbach, London and A. Magdy, Cairo
14:00 A reassessment of the mechanisms of the acute coronary syndromes P. Libby, Boston
14:20 Chronic coronary syndromes: Revascularization strategies (new ESC Guidelines) W. Wijns, Galway
14:40 Chronic coronary syndromes: Diagnostic aspects and noninvasive testing (new ESC Guidelines) J.J. Bax, Leiden
15:00 A patient with chronic coronary syndromes: How to implement the new ESC Guidelines (interactive voting) L. Räber, Berne
15:20 "INOCA" and "MINOCA": Prevalence, prognosis and diagnostic assessment F. Crea, Rome
15:40 Long-term secondary prevention after MI: DAPT, DATT or antiplatelet monotherapy? R.F. Storey, Sheffield
16:00 Panel discussion all
16:15-16:45 COFFEE BREAK  


16:45 - 18:30 | Session 3: Arrhythmias
Chair: S. Haldar, London and T. Wong, London
16:45 Supraventricular tachycardias: How to implement the new ESC Guidelines into clinical practice C. Blomstrom-Lundqvist, Uppsala
17:05 Pathophysiology and management of clinically silent AF B.J. Gersh, Rochester
17:25 Atrial fibrillation: Medical therapy or ablation? A.J. Camm, London
17:45 The Apple Heart Study: Will the smartwatch replace the doctor? P. Kirchhof, Birmingham
18:05 Panel discussion all


Tuesday, December 17th, 2019

Venue: Royal Society of Medicine, London

08:30 - 10:30 | Session 4: Valvular Heart Disease: Catheter-based or Open Surgery?
Chairs: J.J. Bax, Leiden, M. Dalby, Harefield and M. Packer, Dallas

Debate: Aortic stenosis: What is left for surgery?
Very little
Quite a lot
S. Windecker, Berne
M. Arsalan, Frankfurt
09:10 Mitral regurgitation: Mitraclip vs. surgery B. Prendergast, London
09:30 A challenging patient with mitral regurgitation (interactive voting) R. Smith, London
09:50 Tricuspid regurgitation: The new frontier F. Maisano, Zurich
10:10 Panel discussion all
10:30-11:00 COFFEE BREAK  


11:00 - 12:30 | Session 5: Chronic Heart Failure
Chairs: M. Metra, Brescia and F. Mach, Geneva
11:00 Management of HFrEF: From diuretics to ARNI and beyond M. Packer, Dallas
11:20 Evidence-based therapies in HFpEF M. Cowie, London
11:40 New drugs for diabetes and HF S. Anker, Berlin
12:00 Which patients benefit from CRT? J. Cleland, Glasgow
12:20 Panel discussion all


12:30 - 13:00 | Frontieres in Renal Nerve Ablation
Sponsored by Ablative Solutions
Chairs: B. Gersh, Rochester and T.F. Lüscher, London/Zurich
12:30 Renal nerve ablation: Current evidence and future perspectives M. Lobo, London
12:40 Alcohol ablation of renal nerves: A new concept of hypertension management? F. Mahfoud, Homburg/Saar
12:50 Panel discussion all
13:00-13:45 LUNCH BUFFET  


13:45 - 15:15 | Session 6: Acute and Advanced Heart Failure
Chairs: M. G. Crespo Leiro, La Coruña and J. Cleland, Glasgow
13:45 Optimal medical treatment for acute and advanced HF M. Metra, Brescia
14:05 Mechanical circulatory support: Indications and outcome M.R. Mehra, Boston
14:25 Heart transplantation: for whom? M.G. Crespo Leiro, La Coruña
14:45 Palliation and advanced care planning in HF M. Johnson, Hull
15:05 Panel discussion all
15:15-15:30 COFFEE BREAK  


15:30 - 16:30 | Session 7: Cardio-oncology
Chairs: B.J. Gersh, Rochester and M. Mehra, Boston
15:30 Cancer and cardiovascular disease T. Suter, Berne
15:50 Cardiotoxicity of chemotherapy: Which drugs matter? A. Lyon, London
16:10 Amyloidosis: Novel treatment options P.N. Hawkins, London


16:30 - 17:00 | The Paul Hamilton Wood Lecture
Chairs: K. Fox and T.F. Lüscher, London/Zurich
16:30 UK Biobank: A powerful tool to gain novel insights into cardiovascular disease R. Collins, Oxford
17:00 Wrap-up and Close T.F. Lüscher, London/Zurich


Stefan D. Anker
Berlin, DE

Mani Arsalan
Frankfurt, DE

Andreas Baumbach
Bristol, GB

Jeroen J. Bax
Leiden, NL

Carina Blomstrom-Lundqvist
Uppsala, SE

A. John Camm
London, GB

Alberico L. Catapano
Milan, IT

John Cleland
Glasgow, GB

Sir Rory Collins
Oxford, GB

Francesco Cosentino
Stockholm, SE

Martin Cowie
London, GB

Filippo Crea
Rome, IT

Marisa G. Crespo Leiro
La Coruña, ES

Miles Dalby
Harefield, GB

John E. Deanfield
London, GB

Kim Fox
London, GB

Paul A. Friedman
Rochester, US

Bernard J. Gersh
Rochester MN, US

Richard Grocott-Mason
London, GB

Shouvik Haldar
London, GB

Philip N. Hawkins
London, GB

Miriam Johnson
Hull, GB

Paulus Kirchhof
Birmingham, GB

Peter Libby
Boston, US

Melvin D. Lobo
London, GB

Thomas F. Lüscher
London, GB/Zurich, CH

Alexander Lyon
London, GB

François Mach
Geneva, CH

Ahmed Magdy
Cairo, EG

Felix Mahfoud
Homburg/Saar, DE

Francesco Maisano
Zurich, CH

Mandeep R. Mehra
Boston, US

Marco Metra
Brescia, IT

Thomas Münzel
Mainz, DE

Milton Packer
Dallas, US

Bernard Prendergast
London, GB

Lorenz Räber
Berne, CH

Kausik Ray
London, GB

Robert Smith
London, GB

Robert F. Storey
Sheffield, GB

Thomas Suter
Berne, CH

William Wijns
Galway, IE

Stephan Windecker
Berne, CH

Tom Wong
Chelsea, London, GB

Sir Magdy Yacoub
London, GB



Category Price
Registration fees  
Regular fee GBP 300
Early registration fee (before November 16, 2019) GBP 250
ESC / Association Members  
Regular fee GBP 280
Early registration fee (before November 16, 2019) GBP 230
Trainees/Residents, Research fellows, Nurses, Students <35 years (ID proof required)  
Regular fee GBP 150
Early registration fee (before November 16, 2019) GBP 100
Day ticket GBP 150

For group registrations a minimum number of 10 participants is required. Please contact Nadine-Estelle Kaltheuner to obtain further information.

Registration will be confirmed upon receipt of payment.
Please note that UK banks may charge high fees for international bank transfers. We therefore recommend payment by credit card.

Registration Deadline

Online registration closed December 11, 2019. You may register at the venue on the day of the event. Please note: Payment in cash ONLY, in the exact amount.

Modification & Cancellation

All modifications or cancellations must be notified in writing (by mail, fax or e-mail) to Zurich Heart House. For each modification requested by the participant, GBP 50 will be charged for administrative costs. In case of cancellation up to 18 November 2019, deposits will be refunded less GBP 50 for administrative costs. After this date, no refund will be possible.


Zurich Heart House, Foundation for Cardiovascular Research
Dr. Ruth Amstein
Nadine-Estelle Kaltheuner
Hottingerstrasse 14, CH-8032 Zurich, Switzerland
Phone +41 (0) 44 250 40 95, Fax +41 (0) 44 250 40 90


The Royal Society of Medicine
1 Wimpole St, Marylebone, London W1G 0AE, United Kingdom


The Cardiology Update London has been approved by:

Federation of the Royal Colleges of Physicians of the United Kingdom for CPD credits
12 category 1 (external) CPD credits

European Accreditation Council for Continuing Medical Education (AECCME®)
with 11 European CME credits (ECMEC®s)

Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

British Cardiovascular Society